We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care.
- Authors
MacReady, Norra
- Abstract
The article focuses on a study by a research team at New York University (NYU) which examined the effect of psilocybin on patients with late-stage cancer. Information on the patients' dosing regimen is provided. The target number of patients for the study is 32. According to Stephen Ross of NYU School of Medicine, rapid clinical improvement was observed in all subjects. These improvements include decreased anxiety and better relations with families, Ross says.
- Subjects
PHARMACODYNAMICS; CANCER treatment; PSILOCYBIN; DRUG dosage; QUALITY of life; FAMILY relations; ROSS, Stephen; THERAPEUTICS
- Publication
JNCI: Journal of the National Cancer Institute, 2012, Vol 104, Issue 21, p1619
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djs468